US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Adagio Medical Holdings, Inc.

1.39

+0.10007.75%

Post-market: 1.38-0.0100-0.72%19:43 EDT

Volume:171.75K

Turnover:238.83K

Market Cap:21.38M

PE:-0.12

High:1.46

Open:1.29

Low:1.29

Close:1.29

Loading ...

Overview Company News Filings

Press Release: Fiera Capital Appoints Maxime Ménard as Global President and Chief Executive Officer

Circle Receives Abu Dhabi Regulatory Sandbox Approval to Operate as a Money Service Provider

Adagio Medical Holdings Inc. Files Initial Beneficial Ownership Statement for Interim CFO George Dan

Deep Dive into Dubai's Crypto Dream: Illusion, Capital, and Decentralized Empire

BRIEF-Adagio Medical Holdings Inc Appoints Daniel George As Interim CFO - SEC Filing

Adagio Medical Holdings Inc - on April 17 Appoints Daniel George as Interim CFO - SEC Filing

THOMSON REUTERS

Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings

Adagio Medical Gets FDA Breakthrough Device Designation for Cryoablation System; Shares Jump

MT Newswires Live

Dow Falls Over 1%; US Initial Jobless Claims Decline

BRIEF-Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation System

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the Vclastm Cryoablation System

THOMSON REUTERS

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

Chainlink Large Transactions Skyrocket 178%, Is This Sign of LINK Breakout?

M2 Makes Strategic Leadership Appointments to Drive New Institutional and UHNWI Strategy for Growth (7 Apr)

Marex Completes Acquisition of Aarna Capital as it Expands in the Middle East

BRIEF-Adagio Medical Appoints Deborah Kaster As Chief Business Officer

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

THOMSON REUTERS

Adagio Medical Appoints Deborah Kaster as Chief Business Officer

Adaigo Medical Holdings Q4 Revenue $137K Up From $78K YoY

Press Release: Adagio Medical Reports Fourth Quarter and Full Year 2024 Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADGM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADGM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADGM\",,,,,undefined,":{"symbol":"ADGM","market":"US","secType":"STK","nameCN":"Adagio Medical Holdings, Inc.","latestPrice":1.39,"timestamp":1746734400000,"preClose":1.29,"halted":0,"volume":171748,"hourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.39,"latestTime":"19:43 EDT","volume":490,"amount":676.8737,"timestamp":1746747797708},"delay":0,"floatShares":2606901,"shares":15381565,"eps":-11.219569,"marketStatus":"Closed","change":0.1,"latestTime":"05-08 16:00:00 EDT","open":1.29,"high":1.46,"low":1.29,"amount":238829.31666520002,"amplitude":0.131783,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-11.219569,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":5,"adr":0,"listingDate":1614315600000,"exchange":"NASDAQ","adjPreClose":1.29,"preHourTrading":{"tag":"盘前","latestPrice":1.309,"preClose":1.29,"latestTime":"09:08 EDT","volume":283,"amount":366.4339751,"timestamp":1746709702960},"postHourTrading":{"tag":"盘后","latestPrice":1.38,"preClose":1.39,"latestTime":"19:43 EDT","volume":490,"amount":676.8737,"timestamp":1746747797708},"volumeRatio":1.467779},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADGM\",,,,,undefined,":{"symbol":"ADGM","floatShares":2606901,"roa":"-79.06%","roe":"--","lyrEps":-11.219569,"volumeRatio":1.467779,"shares":15381565,"dividePrice":0,"high":1.46,"amplitude":0.131783,"preClose":1.29,"low":1.29,"week52Low":0.625,"pbRate":"1.07","psRate":"35.52","week52High":11.57,"institutionHeld":0,"latestPrice":1.39,"eps":-11.219569,"divideRate":0,"volume":171748,"delay":0,"ttmEps":-11.219569,"open":1.29,"prevYearClose":1.05,"prevWeekClose":1.26,"prevMonthClose":1.29,"prevQuarterClose":0.8049,"fiveDayClose":1.26,"twentyDayClose":0.7745,"sixtyDayClose":1.13},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ADGM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2534167786","title":"Press Release: Fiera Capital Appoints Maxime Ménard as Global President and Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2534167786","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534167786?lang=en_us&edition=fundamental","pubTime":"2025-05-09 05:15","pubTimestamp":1746738900,"startTime":"0","endTime":"0","summary":"Gabriel Castiglio Named Global Chief Operating Officer; Lucas Pontillo Expands Mandate as Global Chief Financial Officer and Head of Corporate Strategy. MONTREAL, May 8, 2025 /CNW/ - Fiera Capital Corporation  , a leading independent asset management firm, today announced the appointment of Maxime Ménard as Global President and Chief Executive Officer, effective July 1, 2025.Jean-Guy Desjardins, Founder of Fiera Capital and Executive Chair of the Board, will continue to provide strategic oversight, shaping the firm's investment philosophy and steering global asset allocation across public markets and multi-asset solutions.\"This decision reflects a clear conviction: Maxime is the right leader to take Fiera Capital forward,\" said Jean-Guy Desjardins. \"He brings the discipline, integrity, and strategic focus required to execute our vision and strengthen the firm for the long term.\". This leadership transition follows the firm's multi-year transformation into a regionally empowered organiz","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM","BK4596","BK4516","BK4600","BK4205","BK4588","BK4023","BK4595","STRK","BK4585","UK","BK4233","BK4528","SAR","BK4135"],"gpt_icon":1},{"id":"2531206140","title":"Circle Receives Abu Dhabi Regulatory Sandbox Approval to Operate as a Money Service Provider","url":"https://stock-news.laohu8.com/highlight/detail?id=2531206140","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531206140?lang=en_us&edition=fundamental","pubTime":"2025-04-29 17:00","pubTimestamp":1745917200,"startTime":"0","endTime":"0","summary":"BlockBeats News, April 29th, according to The Block, the Financial Services Regulatory Authority of the Abu Dhabi Global Market  has granted preliminary approval to the stablecoin issuer Circle, allowing it to operate as a money services provider.This move comes after Circle established a new legal entity within the ADGM in December 2024, aiming to expand its global business presence in the Middle East and Africa region.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info//en/flash/291700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_live","symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2531293239","title":"Adagio Medical Holdings Inc. Files Initial Beneficial Ownership Statement for Interim CFO George Dan","url":"https://stock-news.laohu8.com/highlight/detail?id=2531293239","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2531293239?lang=en_us&edition=fundamental","pubTime":"2025-04-29 05:24","pubTimestamp":1745875445,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings Inc. has filed an initial statement of beneficial ownership. The filing identifies George Dan as the beneficial owner, serving as the Interim CFO of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adagio Medical Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250428:nNDL6VD3ss:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XTNT","BK4198","BK4082","ADGM"],"gpt_icon":0},{"id":"2530644414","title":"Deep Dive into Dubai's Crypto Dream: Illusion, Capital, and Decentralized Empire","url":"https://stock-news.laohu8.com/highlight/detail?id=2530644414","media":"Blockbeats","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530644414?lang=en_us&edition=fundamental","pubTime":"2025-04-28 15:25","pubTimestamp":1745825100,"startTime":"0","endTime":"0","summary":"Original Article Title: \"Web3 Oasis in the Desert: Dubai's Digital Gold Dream\"Original Article Author: Bright, Foresight NewsOn March 12, 2025, Binance announced a $2 billion investment from the Abu D","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theblockbeats.info/en/news/57961","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"theblockbeats_highlight","symbols":["BK4596","BK4194","BK4594","FSP","BK4585","GFCI","ADGM","BK4588","BK4595","TON.USD.HKCC","STRK","BTC.USD.CC","BK4601","TON.USD.CC","BK4023","BK4600","BK4223","BK4516","APT.USD.HKCC","BTC.USD.HKCC","APT.USD.CC","BK4082","GCC"],"gpt_icon":1},{"id":"2529664876","title":"BRIEF-Adagio Medical Holdings Inc Appoints Daniel George As Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2529664876","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529664876?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:08","pubTimestamp":1745442508,"startTime":"0","endTime":"0","summary":"BRIEF-Adagio Medical Holdings Inc Appoints Daniel George As Interim CFO - SEC FilingApril 23  - Adagio Medical Holdings Inc ADGM.O:ADAGIO MEDICAL HOLDINGS INC - ON APRIL 17 APPOINTS DANIEL GEORGE AS INTERIM CFO - SEC FILINGSource text: [ID:n0001558370-25-005261]Further company coverage: ADGM.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R11AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2529665692","title":"Adagio Medical Holdings Inc - on April 17 Appoints Daniel George as Interim CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2529665692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529665692?lang=en_us&edition=fundamental","pubTime":"2025-04-24 04:53","pubTimestamp":1745441632,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R11AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2528728424","title":"Gold Falls Over 1%; D.R. Horton Posts Downbeat Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2528728424","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528728424?lang=en_us&edition=fundamental","pubTime":"2025-04-18 00:09","pubTimestamp":1744906149,"startTime":"0","endTime":"0","summary":" ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44870357/gold-falls-over-1-dr-horton-posts-downbeat-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DHI","LGND","ADGM","CHRO","RTC","GPN","CWD"],"gpt_icon":1},{"id":"2528491007","title":"Adagio Medical Gets FDA Breakthrough Device Designation for Cryoablation System; Shares Jump","url":"https://stock-news.laohu8.com/highlight/detail?id=2528491007","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528491007?lang=en_us&edition=fundamental","pubTime":"2025-04-17 22:24","pubTimestamp":1744899861,"startTime":"0","endTime":"0","summary":"Adagio Medical  said Thursday it has received breakthrough device designation from the US Food and Drug Administration for its vCLAS cryoablation system.The system is intended to treat ventricular tachycardia in people with ischemic or non-ischemic structural heart disease, the company said.The FDA's breakthrough device program is intended to allow patients and healthcare providers to get more timely access to select medical devices, Adagio said.Adagio Medical shares were 160% higher in recent trading.Price: 2.45, Change: +1.57, Percent Change: +180.17","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2528745870","title":"Dow Falls Over 1%; US Initial Jobless Claims Decline","url":"https://stock-news.laohu8.com/highlight/detail?id=2528745870","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528745870?lang=en_us&edition=fundamental","pubTime":"2025-04-17 21:58","pubTimestamp":1744898299,"startTime":"0","endTime":"0","summary":" ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"6a27bb69de7b77a624049dad1cefcd82","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/25/04/44864892/dow-falls-over-1-us-initial-jobless-claims-decline","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USAW.SI","RTC","QLD","LU0566484027.USD","TQQQ","CWD","LGND","BK4135","BK4082","BK4139","PSQ","NVIW.SI","ADGM","TSYW.SI","IOTR","BK4023","QID","USJW.SI","CHRO","BK4007","BK4130","BK4090","NQmain","SQQQ","LU1559883803.SGD","CLIK","MNQmain",".IXIC"],"gpt_icon":1},{"id":"2528712391","title":"BRIEF-Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2528712391","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528712391?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:52","pubTimestamp":1744894333,"startTime":"0","endTime":"0","summary":"BRIEF-Adagio Medical Holdings, Receives FDA Breakthrough Device Designation For The Vclastm Cryoablation SystemApril 17 (Reuters) - Adagio Medical Holdings Inc ADGM.O:ADAGIO MEDICAL HOLDINGS, INC. REC","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7X3DJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2528711267","title":"Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the Vclastm Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2528711267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528711267?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250417:nTUA7X3DJK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2528714618","title":"Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System","url":"https://stock-news.laohu8.com/highlight/detail?id=2528714618","media":"Business Wire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528714618?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"Agency’s Breakthrough Device Designation Program Allows for Priority Review of Ablation Technology for Ventricular Tachycardia. \"Receiving Breakthrough Device Designation is an important milestone for Adagio, validating our proprietary vCLASTM Cryoablation System with our ULTC technology as a potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia,\" said Todd Usen, Chief Executive Officer of Adagio. \"Our team has been working hard to bring this transformational technology to patients, and we are thrilled to be the only technology to be granted Breakthrough Device designation for endocardial treatment of both ischemic and nonischemic structural heart disease patients with sustained monomorphic VT. We are encouraged that, based in part on the strength of the clinical data from our European CRYOCURE-VT study, the FDA has determined that vCLASTM qualifies as a Breakthrough Device, and we look forward to working collaboratively wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagio-medical-holdings-inc-receives-123000953.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADGM","BK4585","BK4588","VT","BK4082"],"gpt_icon":0},{"id":"2526463388","title":"Chainlink Large Transactions Skyrocket 178%, Is This Sign of LINK Breakout?","url":"https://stock-news.laohu8.com/highlight/detail?id=2526463388","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526463388?lang=en_us&edition=fundamental","pubTime":"2025-04-08 15:14","pubTimestamp":1744096440,"startTime":"0","endTime":"0","summary":"Decentralized oracle platformChainlink has seen its native token, LINK, surge in whale activity over the last 24 hours. This uptick in large transactions comes amid a broader market uptrend, which has","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/chainlink-large-transactions-skyrocket-178-is-this-sign-of-link-breakout","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["BK4157","LINK.USD.HKCC","LINK.USD.CC","LINK","BK4082","ADGM"],"gpt_icon":0},{"id":"2525035062","title":"M2 Makes Strategic Leadership Appointments to Drive New Institutional and UHNWI Strategy for Growth (7 Apr)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525035062","media":"CoinMarketCap","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525035062?lang=en_us&edition=fundamental","pubTime":"2025-04-07 15:49","pubTimestamp":1744012163,"startTime":"0","endTime":"0","summary":"M2 a leading platform for secure, regulated, and innovative digital asset trading and investment, today announced the appointment of James Greenwood as Chief Executive Officer and Bill Qian as Managing Director. Bijan Alizadeh will continue in his role as Board Member and Shareholder Representative. These leadership appointments signal a strategic step forward as M2 strengthens its position in the global digital finance landscape.This announcement marks a significant phase of growth and strategic refocus for M2, aligning with its ambition to become a one-stop digital asset financial service platform, serving global users from the Middle East. The new leadership structure reinforces M2’s ongoing commitment to regulated financial services and to meeting the evolving needs of institutional and high-net-worth clients.Building on the success of its flagship earn product and growing demand for yield-oriented and financing solutions, M2 has restructured its treasury division to better serve u","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://coinmarketcap.com/community/articles/67f383860ad92168ac836aed/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"coinmarketcap_highlight","symbols":["STRK","BK4023","BK4588","BK4516","BK4082","ADGM","BK4595","BK4585","BK4600","BK4596"],"gpt_icon":1},{"id":"2524495564","title":"Marex Completes Acquisition of Aarna Capital as it Expands in the Middle East","url":"https://stock-news.laohu8.com/highlight/detail?id=2524495564","media":"GlobeNewswire","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524495564?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"LONDON, April 02, 2025  -- Marex Group plc, the diversified global financial services platform, today announces the completion of its acquisition of Aarna Capital Limited  expanding its operations in the Middle East and growing its clearing business, in line with its strategy to broaden its client base, diversify its operations and increase earnings resilience.Based in Abu Dhabi, Aarna Capital provides clearing, execution and customised risk management solutions in energy, base and ferrous metals, as well as financial markets such as equities, fixed income and FX.Aarna Capital is a multi-asset brokerage firm, operating from Abu Dhabi Global Markets  and offering customers access to futures, options, FX, Bullion, equities, CFDs and fixed income products. From its headquarters, Aarna Capital combines the talent and experience of its hands-on traders with the innovative electronic platform, global liquidity network, and high-speed market infrastructure. Aarna Capital’s customers have acce","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/marex-completes-acquisition-aarna-capital-200500623.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MRX","BK4127","BK4082","ADGM"],"gpt_icon":0},{"id":"2524972257","title":"BRIEF-Adagio Medical Appoints Deborah Kaster As Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524972257","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524972257?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:29","pubTimestamp":1743452994,"startTime":"0","endTime":"0","summary":"BRIEF-Adagio Medical Appoints Deborah Kaster As Chief Business OfficerMarch 31 (Reuters) - Adagio Medical Holdings Inc ADGM.O:ADAGIO MEDICAL APPOINTS DEBORAH KASTER AS CHIEF BUSINESS OFFICERSource text: ID:nBw329wsvaFurther company coverage: ADGM.O ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA5QBHWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2524743309","title":"Adagio Medical Appoints Deborah Kaster as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524743309","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524743309?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:01","pubTimestamp":1743451260,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250331:nTUA5QBHWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADGM","BK4082"],"gpt_icon":0},{"id":"2524903342","title":"Adagio Medical Appoints Deborah Kaster as Chief Business Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2524903342","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524903342?lang=en_us&edition=fundamental","pubTime":"2025-04-01 04:01","pubTimestamp":1743451260,"startTime":"0","endTime":"0","summary":"LAGUNA HILLS, Calif., March 31, 2025----Adagio Medical , a leading innovator in catheter ablation technologies for treatment of cardiac arrhythmias, is pleased to announce the appointment of Deborah Kaster as Chief Business Officer . Kaster brings more than 25 years of leadership experience in strategy, mergers and acquisitions, corporate finance, investor relations and strategic communications in the medical technology sector.Most recently, Kaster served as Vice President of Investor Relations at Shockwave Medical, where she played a pivotal role in the company’s growth from IPO to its acquisition by Johnson & Johnson. During her time at Shockwave, the company’s stock price appreciated nearly 2000%, a testament to her strategic vision and communications expertise.Adagio Medical is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias utilizing its novel, proprietary, catheter-based Ultra-Low Temperature Cryoablation  techn","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adagio-medical-appoints-deborah-kaster-200100652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4082","ADGM"],"gpt_icon":0},{"id":"2523949665","title":"Adaigo Medical Holdings Q4 Revenue $137K Up From $78K YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949665","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949665?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:38","pubTimestamp":1743424708,"startTime":"0","endTime":"0","summary":"Adaigo Medical Holdings Q4 Revenue $137K Up From $78K YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44560481/adaigo-medical-holdings-q4-revenue-137k-up-from-78k-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADGM"],"gpt_icon":0},{"id":"2523949360","title":"Press Release: Adagio Medical Reports Fourth Quarter and Full Year 2024 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2523949360","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523949360?lang=en_us&edition=fundamental","pubTime":"2025-03-31 20:30","pubTimestamp":1743424200,"startTime":"0","endTime":"0","summary":"Adagio Medical Holdings, Inc. , a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today reported financial results for the fourth quarter and full year ended December 31, 2024.-- Reported total company revenue of $137 thousand in the fourth quarter of. revenue for 2024 was $0.6 million compared to $0.3 million in 2023.-- Surpassed 40% enrollment in the FULCRUM-VT pivotal study. The results of. the study will be used to support FDA premarket approval  for. Adagio's VT Cryoablation System for endocardial ablation of scar-mediated. ventricular tachycardia . The study, which seeks to enroll 206. centers, is on track for completion of patient enrollment in the second. US pivotal investigational device exemption clinical trial activities and. -- Reported cash, cash equivalents, and short-term investments of $20.6. Operating expenses for the fourth quarter of 2024 were $56.7 million, compared to $5.1 million for the fourth quarter of 2023. The inc","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4555","BK4585","BK4604","TM","VT","03160","ADGM","BK4099","BK4588"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":66,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADGM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-08-01","symbol":"ADGM","reason":null,"defaultRemindTime":1722519000000,"announcedDate":"2024-07-31","type":"delisting","dateTimestamp":1722484800000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADGM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADGM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADGM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADGM","date":"2025-05-07","current":-0.258269,"percent":0.874317,"low":-2.12675,"twenty":-1.36545,"median":-0.882667,"eighty":-0.478184,"high":-0.064118,"avg":-0.907096,"sd":0.514439,"marketCap":19380771},"quantilePoints":[{"date":"2024-08-16","current":-1.923511,"twenty":-2.109329,"median":-2.032425,"eighty":-1.910446,"marketCap":70954470},{"date":"2024-08-23","current":-1.887218,"twenty":-2.104974,"median":-1.996096,"eighty":-1.916252,"marketCap":69615707},{"date":"2024-08-30","current":-1.702126,"twenty":-2.046935,"median":-1.923511,"eighty":-1.821166,"marketCap":62788012},{"date":"2024-09-06","current":-1.589618,"twenty":-2.028048,"median":-1.887218,"eighty":-1.687609,"marketCap":58637845},{"date":"2024-09-13","current":-1.397267,"twenty":-1.990289,"median":-1.854555,"eighty":-1.571472,"marketCap":51542398},{"date":"2024-09-20","current":-1.473482,"twenty":-1.956174,"median":-1.702126,"eighty":-1.526469,"marketCap":54353802},{"date":"2024-09-27","current":-1.315681,"twenty":-1.933673,"median":-1.600506,"eighty":-1.408155,"marketCap":45785715},{"date":"2024-10-04","current":-0.969257,"twenty":-1.901735,"median":-1.575101,"eighty":-1.31919,"marketCap":33730148},{"date":"2024-10-11","current":-1.057931,"twenty":-1.887218,"median":-1.536994,"eighty":-1.105634,"marketCap":36815999},{"date":"2024-10-18","current":-1.106019,"twenty":-1.87633,"median":-1.481466,"eighty":-1.083537,"marketCap":38489453},{"date":"2024-10-25","current":-1.038696,"twenty":-1.862539,"median":-1.40634,"eighty":-1.077166,"marketCap":36146617},{"date":"2024-10-31","current":-1.067164,"twenty":-1.855281,"median":-1.373677,"eighty":-1.074858,"marketCap":37137302},{"date":"2024-11-08","current":-1.038696,"twenty":-1.814633,"median":-1.315681,"eighty":-1.05947,"marketCap":36146617},{"date":"2024-11-15","current":-1.78348,"twenty":-1.774166,"median":-1.248504,"eighty":-1.043312,"marketCap":49668129},{"date":"2024-11-22","current":-1.189993,"twenty":-1.736967,"median":-1.273501,"eighty":-1.044098,"marketCap":33140110},{"date":"2024-11-29","current":-1.476013,"twenty":-1.694867,"median":-1.315681,"eighty":-1.047159,"marketCap":38808813},{"date":"2024-12-06","current":-1.243831,"twenty":-1.654945,"median":-1.318605,"eighty":-1.057931,"marketCap":32704056},{"date":"2024-12-13","current":-1.185786,"twenty":-1.607039,"median":-1.293585,"eighty":-1.0587,"marketCap":31177866},{"date":"2024-12-20","current":-1.017178,"twenty":-1.587441,"median":-1.275501,"eighty":-1.043976,"marketCap":26744650},{"date":"2024-12-27","current":-0.585983,"twenty":-1.578731,"median":-1.271472,"eighty":-1.038696,"marketCap":15407244},{"date":"2025-01-03","current":-0.646792,"twenty":-1.575827,"median":-1.231669,"eighty":-1.023188,"marketCap":17006109},{"date":"2025-01-10","current":-0.555578,"twenty":-1.569657,"median":-1.18789,"eighty":-1.00708,"marketCap":14607811},{"date":"2025-01-17","current":-0.454911,"twenty":-1.565879,"median":-1.116684,"eighty":-0.967795,"marketCap":11960963},{"date":"2025-01-24","current":-0.509252,"twenty":-1.557895,"median":-1.111789,"eighty":-0.9166,"marketCap":13389767},{"date":"2025-01-31","current":-0.552814,"twenty":-1.538809,"median":-1.10121,"eighty":-0.630208,"marketCap":14535136},{"date":"2025-02-07","current":-0.597039,"twenty":-1.526469,"median":-1.078666,"eighty":-0.615835,"marketCap":15697946},{"date":"2025-02-14","current":-0.685489,"twenty":-1.507162,"median":-1.077166,"eighty":-0.610306,"marketCap":18023568},{"date":"2025-02-21","current":-0.823693,"twenty":-1.480375,"median":-1.077166,"eighty":-0.614729,"marketCap":21657352},{"date":"2025-02-28","current":-0.851333,"twenty":-1.476013,"median":-1.067164,"eighty":-0.620258,"marketCap":22384109},{"date":"2025-03-07","current":-0.610859,"twenty":-1.475507,"median":-1.057931,"eighty":-0.59925,"marketCap":16061325},{"date":"2025-03-14","current":-0.569398,"twenty":-1.466249,"median":-1.043853,"eighty":-0.585983,"marketCap":14971190},{"date":"2025-03-21","current":-0.478184,"twenty":-1.435658,"median":-1.038696,"eighty":-0.581561,"marketCap":12572892},{"date":"2025-03-28","current":-0.525173,"twenty":-1.428191,"median":-1.038696,"eighty":-0.574926,"marketCap":13808379},{"date":"2025-04-04","current":-0.162136,"twenty":-1.422971,"median":-1.019942,"eighty":-0.558342,"marketCap":12166817},{"date":"2025-04-11","current":-0.159881,"twenty":-1.411785,"median":-1.000226,"eighty":-0.552814,"marketCap":11997620},{"date":"2025-04-17","current":-0.189233,"twenty":-1.397267,"median":-0.992532,"eighty":-0.536506,"marketCap":14200260},{"date":"2025-04-25","current":-0.233672,"twenty":-1.397267,"median":-0.952693,"eighty":-0.516826,"marketCap":17534984},{"date":"2025-05-02","current":-0.258269,"twenty":-1.36545,"median":-0.912143,"eighty":-0.492004,"marketCap":19380771},{"date":"2025-05-07","current":-0.258269,"twenty":-1.36545,"median":-0.882667,"eighty":-0.478184,"marketCap":19380771}],"updateTime":1746749648714}}}